非编码RNA与乳腺癌治疗相关后遗症:当前证据与展望
本文综述乳腺癌多模式治疗(手术、化疗、放疗、内分泌及靶向治疗)后长期副作用(神经病变、心脏毒性、纤维化)的分子机制,汇总非编码RNA(miRNA、lncRNA、circRNA)通过调控凋亡、氧化应激、炎症及细胞外基质重塑影响这些并发症的证据,强调其作为诊断、预后及治疗工具的潜力。
要点
- 乳腺癌治疗相关后遗症包括神经病变、心脏毒性和纤维化,显著降低生存者生活质量。
- ncRNA通过调控凋亡、氧化应激、炎症和细胞外基质重塑影响并发症发生发展。
- ncRNA有潜力作为诊断、预后及治疗工具,改善生存和个体化护理。
核心结论
- 非编码RNA在乳腺癌治疗相关后遗症的分子机制中起关键调控作用,并具有诊断、预后和治疗潜力。
研究设计与样本
- 综述类文章,检索范围未在摘要中明确报告。
主要发现
- 乳腺癌多模式治疗改善生存率,但长期副作用如神经病变、心脏毒性和纤维化抵消部分获益。
- miRNA、lncRNA和circRNA调控凋亡、氧化应激、炎症及细胞外基质重塑等过程,影响治疗相关并发症。
临床怎么用
- ncRNA有望作为诊断、预后及治疗工具,用于改善乳腺癌生存者生活质量和个体化癌症护理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breast cancer (BC) is the most common malignancy among women worldwide. Advances in multimodal treatments-including surgery, chemotherapy, radiotherapy, endocrine therapy, and targeted therapies-have significantly improved survival rates. However, these improvements are often offset by long-term side effects such as neuropathy, cardiotoxicity, and fibrosis, which greatly diminish survivors' quality of life. Recent discoveries in non-coding RNA (ncRNA) biology have transformed our understanding of the molecular mechanisms behind both treatment effectiveness and associated toxicities. Non-coding RNAs-including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs)-regulate vital processes like apoptosis, oxidative stress, inflammation, and extracellular matrix remodeling, thereby influencing the development and progression of these complications. In this review, we provide an update on the main side effects of traditional BC treatments and compile current evidence linking ncRNAs to the molecular and cellular processes that drive these treatment-related issues, emphasizing their potential as diagnostic, prognostic, and therapeutic tools to improve survivorship and personalized cancer care.
引用
- Montanari J, Vinasco-Sandoval T, Lemaître G, et al. Non-coding (nc) RNAs and breast cancer treatment related sequelae: Current evidence and perspectives. Radiother Oncol. 2026. PMID: 42119641. doi:10.1016/j.radonc.2026.111570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。